Shareholders' equity · 2011–2025
Pacira Biosciences shareholders' equity
$693M−11.0% · FY2025
Pacira Biosciences (PCRX) reported $693M in shareholders' equity for fiscal 2025, −11.0% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $693M | −11.0% | Open → |
| FY20242024-12-31 | $778M | −10.5% | Open → |
| FY20232023-12-31 | $870M | +12.3% | Open → |
| FY20222022-12-31 | $775M | +6.1% | Open → |
| FY20212021-12-31 | $730M | +17.9% | Open → |
| FY20202020-12-31 | $620M | +74.6% | Open → |
| FY20192019-12-31 | $355M | +10.5% | Open → |
| FY20182018-12-31 | $321M | +14.9% | Open → |
| FY20172017-12-31 | $279M | +27.6% | Open → |
| FY20162016-12-31 | $219M | +0.3% | Open → |
| FY20152015-12-31 | $218M | +27.6% | Open → |
| FY20142014-12-31 | $171M | +314.9% | Open → |
| FY20132013-12-31 | $41.2M | −37.4% | Open → |
| FY20122012-12-31 | $65.9M | +36.4% | Open → |
| FY20112011-12-31 | $48.3M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +21.0%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Pacira Biosciences shareholders' equity |url=https://companiesranked.com/en/company/pacira-biosciences/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Pacira Biosciences shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/pacira-biosciences/shareholders-equityBibTeX
@misc{companiesranked-en-company-pacira-biosciences-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Pacira Biosciences shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/pacira-biosciences/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001628280-26-052635 · August 4, 2026
{{cite web |title=Pacira Biosciences shareholders' equity — 10-Q (0001628280-26-052635) |url=https://www.sec.gov/Archives/edgar/data/1396814/000162828026052635/pcrx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.